Status:
ENROLLING_BY_INVITATION
Exploring the Application Value of New Magnetic Resonance Imaging Technologies in Non-invasive Quantitative Assessment of Graft Function After Liver Transplantation
Lead Sponsor:
Zhen Li
Conditions:
Liver Transplantation
MRI
Eligibility:
All Genders
18-80 years
Brief Summary
Title: Exploring the Application Value of New Magnetic Resonance Imaging Technologies in Non-invasive Quantitative Assessment of Graft Function after Liver Transplantation Purpose of the Study: This...
Detailed Description
Title: Exploration of New Magnetic Resonance Imaging Technologies for Non-invasive Quantitative Assessment of Graft Function after Liver Transplantation Principal Investigator: Professor Li Zhen Res...
Eligibility Criteria
Inclusion
- Patients who have undergone liver transplantation.
- Patients who are scheduled for MR imaging post-transplant.
- Voluntary participation with signed informed consent.
Exclusion
- Patients with contraindications for MRI, such as pacemakers, unknown metallic implants, or neurostimulators.
- Patients with claustrophobia or inability to tolerate the required breath-holds for MRI.
- Patients who cannot comply with the study requirements.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06994429
Start Date
June 1 2024
End Date
September 1 2030
Last Update
May 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji hospital, NO.1095 jiefang avenue
Wuhan, Hubei, China, 430074